Novotech and PPC Group Announce Strategic Partnership

Partnership Creates Region’s Largest Biotech CRO Platform to Meet Demand for Clinical Trials

Novotech’s Clinical Network Services wins GENE Awards for Industry excellence in biotech drug…

Clinical Network Services, a subsidiary of Novotech, the Asia-Pacific CRO, was awarded a prestigi

Novotech discusses biotechnology CRO services at leadership meeting in Malaysia

Novotech is a full service CRO, offering CRO services across all the Asia-Pacific region with ope

Asia-Pacific shows higher patient recruitment rates for Oncology clinical trials

Biotechnology companies are facing tremendous challenges around patient recruitment, lengthy time

Ovarian cancer landscape in the Asia-Pacific region

We are seeing a growing amount of 

Novotech discusses biotech clinical development plans in Asia and Australia at OCT conference in…

We’re in Boston and we are seeing tremendous interest from 

Novotech sees increased interest from US biotechs in Asia-pacific at OCT Southern California in La…

Novotech is focused on serving the biotech sector in the Asia Pacific region, we work with the mo

Novotech CRO Finalist in International Health Awards 2019

Sydney, Australia - Asia-Pacific specialist CRO Novotech has we

Novotech facilitates flexible working to become the workplace of choice in the CRO services…

Novotech CRO, the leading Asia-Pacific CRO, continues expansion to deliver high quality clinical

Orphan Drugs - Clinical trial landscape in Asia-Pacific

We have observed an unprecedented global effort in the clinical development of Orphan drugs

Novotech CRO at 2019 KoNECT-MOHW-MFDS International Conference, Seoul, South Korea

Seoul, South Korea – Award-winning Asia-Pacific specialist CRO Novotechwill atte

Novotech CRO presents benefits of working with the leading Asia-Pacific CRO in Beijing and…

Beijing/Shanghai, China – Award-winning Asia-Pacific specialist CRO Novotech is

Novotech CRO says South Korea’s Five-Year Plan for the Advancement of Clinical Trials will further…

Asia-Pacific specialist CRO Novotech has welcomed the South Korean C

Novotech CRO partners with the Skin Research Institute of Singapore (SRIS) for skin disorders…

Novotech, the award-winning Asia-Pacific CRO, with 23 years of experience in the region, has furt

Novotech launches new site management organisation (SMO) business in South Korea

19 July 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO Novotech announced

Trials In Focus

Trials In Focus August 25, 2010

Novotech Update: Novotech presents to Chinese biotechs on 3 key benefits of early stage clinical…

Novotech presented to a number of biotechnology companies based at China’s 

Asian Century and clinical trials: Issues for consideration by biotechnology companies

Together with already large pharmaceutical markets such as Japan, it is not difficult to see why

Novotech Update: EMA releases addendum to ICH Guidelines, highlighting importance of considering…

The European Medicines Agency (EMA) recently released an addendum regarding International Confere

BioSpectrum India: Novotech remains very optimistic about the future of clinical trials in India

Many of these challenges have now been resolved, but the reality is that sponsors have been much

Trials In Focus

April 19, 2010 Novotech partners with Citeline

New Study of Investigational Alzheimer’s Disease Treatment Enrolling Patients in Australia

August 31, 2009

Novotech signs MOU with South Korea’s SCI-Consortium and Severance Hospital

31 July 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO No

ARCS 2017: Australia plays a key role in bringing clinical research to Asia, says Novotech

During a panel discussion at this year’s ARCS 2017, Novotech CEO Dr John Moller discussed Austral

Novotech Update: South Korea to cover standard of care for patients participating in clinical trials

In a recent update, South Korea’s National Health Insurance Program outlined plans to also cover

Accelerating Clinical Trials in Asia 2017: Changes to Asia’s regulatory environment increasing its…

Presenting at this year’s Accelerating Clinical Trials in Asia 2017, Novotech CRO Executive Direc

Novotech Update: Novotech and Deloitte brief biotech companies on benefits of accessing Australia’s…

10 January 2017; San Francisco, California, United States: At a private event du

Outsourcing Clinical Trial South California 2017: Regulatory change is increasing Asia’s…

At this year’s Outsourcing Clinical Trial South California 2017, Novotech Director Mr Barry Murph

NZACRes 2017: Novotech outlines opportunities for New Zealand to increase clinical trial…

Presenting at NZACRes 2017, Novotech warned New Zealand must continue to invest in areas where it

CenterWatch

Novotech Becomes Medidata Solutions’ Partner

Alchemia Recruits Full Patient Quota to Pivotal Phase III HAIrinotecan Trial in Metastatic…

Brisbane, Australia 4th Feb 2013: Brisbane-based drug discovery and development company Alchemia

Novotech wins 2017 Asia Pacific Biotech CRO award

Leading Asia Pacific CRO Novotech has won Asia Pacific Biotech CRO Company of The Year a

Sponsors Recommend Novotech for CRO Leadership Award

Asia-Pacific specialist CRO Novotech has been awarded the “Exceeded Customer Expectations” Award

Novotech and CNS deal expands CRO services for biopharma clients across Asia-Pacific

Novotech the largest Asia-Pacific-based CRO has acquired Australasian specialist CRO Clinical Net

Australia and Asia Pacific offer international biotech industry a wealth of clinical trial and…

Australia and the Asia Pacific are fast becoming the destination of choice for the over US$140 bi

Pharma Tech Outlook Magazine features Novotech in the top 10 CROs of the year

See Top 10 CRO article here

Outsourcing Pharma

Outsourcing Pharma 2nd June 2010

Novotech CRO Expands China Team as Biotech Demand for Clinical Trials Increases up to 79%

Originally published on 

Novotech Update: Asia’s international clinical trial profile will continue to increase in 2018,…

Presenting at this year’s Outsourcing Clinical Trials East Asia 2017 in Seoul, Novotech CRO Chief

TheraVida Initiates Phase 2 Trial of THVD-201 for Overactive Bladder and Urinary Incontinence:…

TheraVida Initiates Phase 2 Trial of T

Novotech Partners with Medidata to Accelerate Clinical Research Discoveries in Asia-Pacific

Leading Asia-Pacific CRO and Medidata partner to enable smarter, faster drug development

Why South Korea Is The Hottest Growth Spot For Clinical Trials

By Ed Miseta, Chief Editor, Clinical Leader – Originally published in Life Science Leader mag

World Pharma Today: Increasing clinical trial competition within Asia to benefit sponsors says…

In an article drafted for World Pharma Today, Novotech explains on how increasing clinical trial

BioSpectrum Asia interviews Dr Yooni Kim on how she is growing the next generation of female…

Novotech Update: China implements 5 key changes to accelerate clinical trial and drug approval…

With patients in China having to wait a minimum of six years to access medications already approv

NOVOTECH CRO EXPANDS ASIA REGION SERVICES WITH NEW CHINA OFFICE IN SHANGHAI

NOVOTECH CRO EXPANDS ASIA REGION SERVICES WITH NEW CHINA OFFICE IN SHANGHAI

Scrip Clinical Research News

June 2, 2010

The Road Less Travelled – Navigation through the do’s and don’ts of running Oncology studies in…

Listen to the webinar

Novotech Awarded Asia-Pacific Biotech CRO of the Year - Announced at ASCO

The announcement was made at the ASCO Annual Meeting (May 31 - June 4, 2019  McCormick Place, Chi

Novotech CRO announces several key Hospital Partnerships in India and Thailand at OCT West Coast…

Asia-Pacific specialist CRO Novotech announced at OCT West 2019 a new powerful clinical partnersh

Webinar - Navigating Oncology Trials in Asia: How a Regional CRO can Deliver on a Global Project

Almost half of these occur in Asia with almost one quarter of the global burden in China.

Novotech announces transition of CEO role

“John brings tremendous leadership to Novotech, and a proven track record of success.

Novotech Update: Three clinical trial and regulatory updates you need to know for your next…

FDA agrees to IRB Waivers for Minimal Risk Studies 

Novotech signs MOU with South Korea’s leading medical center, the Asan Medical Center

15 April 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO N

Novotech CRO featured as top 10 Asia-Pacific firm by Insights Care Magazine

Insights Care Magazine research team featured Novotech CRO in the May 2019 cover story “The 10 Co

Webinar - Clinical Trial Planning in Asia: A Roadmap for Biotech Sponsors

However, as attractive as Asia may be, navigating the maze of trial logistics, local regulations

Pharmaceutical Business Review

PBR Staff

Novotech CRO Says Australia is Gateway to Asia Clinical Research, at Industry Event in Seoul

Asia-Pacific specialist CRO Novotech presented Australia's R&D Refund and Simplified Regulato

Novotech - A Catalyst for Growth and a Better Tomorrow

The cost of research for new drugs has almost tripled over the last 25 years and new models are e

Novotech and CNS Awarded Top Asia-Pacific CRO

This is the second year that Novotech, the largest Asia-Pacific-based CRO, has been selected as a

World Pharma Today: Increasing clinical trial competition within Asia to benefit sponsors says…

In an article drafted for World Pharma Today, Novotech explains on how increasing clinical trial

Novotech Partners with Asian Eye Institute for Accelerated Ophthalmic Drug and Devices Clinical…

Asia-Pacific specialist CRO Novotech announced today it has partnered with the Asian Eye Institut

Novotech Signs MOU with Clinical Research Malaysia

Novotech Malaysia has signed a Memorandum of Understanding with Clinical Research Malaysia (CRM)

Novotech CRO and Clinical Network Services (CNS) Announced as Finalists in 2019 Clinical & Research…

BOSTON – February, 25 – Novotech CRO and subsidiary Clinical Network Services (CNS) have been nam

Novotech CRO Awarded Frost & Sullivan Leading Biotech CRO in the Asia-Pacific

Asia-Pacific specialist CRO Novotech has been awarded the top Asia-Pacific CRO by Frost & Sul

Novotech CRO Presents Australia and Asia-Pacific Clinical Trial Trends and Latest Tax Breaks for…

Asia-Pacific specialist CRO Novotech has been invited to share the advantages of

Novotech CRO Launches Largest Oracle Trial Management and Monitoring Cloud Service Implementation…

Asia-Pacific specialist CRO Novotech announced as part of its ongoing IT infrastructure investmen

Novotech embarks on a new strategic partnership with Citeline, designed to accelerate patient…

15 April 2010

The Australian Government recently announced a new commitment of $100m to support rural, regional,…

Commenting on the news, Novotech CEO, Dr.

Novotech Signs MOU with China Medical University Hospital in Taiwan to Offer Enhanced Services for…

Asia-Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding

Novotech Signs MOU with King Chulalongkorn Memorial Hospital, Srinagarind Hospital and…

Novotech has partnered with several major sites in Thailand to facilitate high-quality and rapid

Novotech signs central lab services agreement with Sonic Clinical Trials

19 June 2017, Sydney, Australia: Asia Pacific specialist CRO Novotech announced

Novotech CRO strengthens South Korean clinical capabilities by partnering with major hospitals

Novotech, the award-winning Asia-Pacific CRO, with 23 years of experience in the region, has furt

Trials In Focus

Trials In Focus June 21, 2010

Considerations for Asia Pacific clinical trials

The acceptability of data worldwide, a keen and well-qualified investigator community and sheer n

Novotech Update: India streamlines clinical trial approval process and reduces regulatory timelines

Minuted in June 2017, the Drug Controller General of India (DCGI) and Secretary of Health and Fam

CentreWatch Weekly covers Novotech's rapid growth in South Korea

July has been a big month for Novotech in South Korea.

Novotech Update: Novotech and Deloitte Launch U.S. Biotech Briefings about 60% Savings for Early…

Sydney, Australia – October 27, 2016: In an industry first Novotech and Deloitte

Novotech initiates cancer trials in Australia and New Zealand for Oncomed Pharmaceuticals

Novotech initiates cancer trials in Australia and New Zealand for Oncomed Pharmaceuticals

Novotech receives ISO 9001:2015 certification

29 June 2017, Sydney, Australia: Asia Pacific specialist CRO Novotech announced today it has rece

Novotech kicks off Phase Ib trials in Australia and NZ for OncoMed

Novotech kicks off Phase Ib trials in Australia and NZ for OncoMed

Novotech Update: Malaysian government invests in its early stage research industry and launches new…

Malaysia’s clinical trials industry body Clinical Research Malaysia (CRM) has launched the countr

CIO

  Novotech Selects Oracle’s Siebel Clinical Trial Management

Australian CRO Novotech announces expanded Asia reach into Hong Kong and Philippines at DIA 2013

As a leading regional CRO, Novotech has been actively involved in hundreds of drug development pr

Novotech Update: Novotech shares the importance of good clinical trial project management with…

Novotech recently delivered an educational workshop on the importance of ‘Timeline Management and

Novotech Update: 8 reasons why Australia should be your next clinical trial destination

Australia is internationally recognised for its superior clinical research and healthcare infrast

Novotech announces four country Asia expansion at AusBiotech 2009

October 27, 2009

Clinical Trial Planning in Asia: A Roadmap for Biotech Sponsors, Upcoming Webinar Hosted by Xtalks

Clinical Trial Planning in Asia: A Roadmap for Biotech Sponsors, Upcoming Webinar Hosted

iTnews

Novotech runs clinical trials on Oracle 26th October 2010

Novotech appointed Contract Research Organisation for upcoming Phase 1b/2 study of HER-Vaxx in…

Imugene’s clinical review for HER-Vaxx is now complete HER-Vaxx Phase 1b/2 in gast

Novotech Update: 8 reasons why China should be your next clinical trial destination

Happy Chinese New Year!

Novotech recognised as Asia Pacific growth leader by Frost & Sullivan research analysts

Sydney, Australia: 

Novotech wins ‘Australian Exporter of The Year’ at the India Australia Business Community Awards

Novotech has been awarded ‘Australian Exporter of The Year’ the 2017 Indian Australia Business Co

NOVOGEN ENGAGES CONTRACT RESEARCH ORGANISATION TO CONDUCT CANTRIXIL PHASE 1 CLINICAL TRIAL

Sydney, November 24, 2015 - US-Australian drug discovery company, Novogen Limited (ASX:NRT: NASDA

SureClinical eTMF Cloud Selected by Novotech to automate and accelerate clinical operations…

SureClinical eTMF Cloud Selected by Novotech to automate an

Novotech named a finalist in the 2017 Premier’s NSW Export Awards

Novotech has been named as a finalist in the Health and Biotechnology category of the upcoming 20

BioSpectrum Asia: Australia - A thriving lifescience hub with a global reach

In an interview with BioSpectrum Asia, Novotech CEO Dr John Moller provides his thoughts on the s

Novotech receives CRO Leadership Awards recognition from Life Science Leader

Life Science Leader Magazine featured Novotech in its May edition’s CRO supplement and attributed

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Gr

NOVOTECH CRO ANNOUNCES MOU WITH KOREA DRUG DEVELOPMENT FUND (KDDF) AT DIA 2014

San Diego, CA, June 15, 2014 | Novotech, Australia’s largest clinical CRO with o

Novotech leads the fast growing Asia Pacific clinical research sector with another Frost & Sullivan…

Sydney, Australia, February 17, 2015

Video Recording: Australia: Preferred Destination for Early Phase Clinical Trials

 The study was supported by Novotech, Australia’s largest independent clinical contract research

Novotech and Deloitte Launch U.S. Biotech Briefings about 60% Savings for Early Phase Clinical…

Sydney, Australia – October 27, 2016 In an industry first Novotech and Deloitte have teamed up to

Novotech Update: Five things you need to know about China’s changing clinical trial environment

Novotech Update: New policy reforms in China focus on reducing clinical trial start up ti

Australian clinical research company expands operation in Hong Kong

Sydney-based Novotech today (January 15) announced that it has expanded its Hong Kong operation i

Medidata Solutions Welcomes First Australian CRO to ASPire to Win Channel Partner Program

– Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development

Experienced Australian CRO attains Medidata accreditation to offer enhanced clinical trial services

Media contact: Susan Fitzpatrick-Napier DMG

Herpes Zoster Novel Treatment Hope From Tasmanian Abalone Gets $1.2 Million Boost

The team aims to commercialize a novel treatment for Herpes simplex and Herpes zoster utilizing a

Novotech Recognized as Asia Pacific Growth Leader by Frost & Sullivan Research Analysts

In recognising Novotech for the prestigious award, Frost & Sullivan’s Asia Pacific Healthcare

Novotech Update: Taiwan simplifies its First In Human regulatory process, reducing timelines by up…

The Taiwanese Ministry for Health and Welfare Food and Drug Administration (TFDA) recently announ

Novotech CEO to speak on Clinical Projects – Faster and Smarter it’s All in the Planning at the…

Novotech CEO to speak on Clinical Projects – Faster and Smarter it’s All in the Planning

NOVOTECH CRO ATTRACTS INVESTMENT FOR ASIA CLINICAL TRIAL EXPANSION

NOVOTECH CRO ATTRACTS INVESTMENT FOR ASIA CLINICAL TRIAL EXPANSION